NRIX Revenue Flow Filed revenue amounts for 2026-03-01 to 2026-05-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-05-31: Revenue $9.04M ; Research and development $87.65M ; Operating expenses $103.25M ; Income tax -$271.00K . 2026-02-28: Revenue $6.25M ; Research and development $84.14M ; Operating expenses $98.75M ; Income tax $0.00 . 2025-11-30: Revenue $13.58M* ; Research and development $83.02M* ; Operating expenses $96.67M* ; Income tax $0.00* . 2025-08-31: Revenue $7.89M ; Research and development $86.12M ; Operating expenses $99.28M ; Income tax $0.00 . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
NRIX revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Collaboration Revenue $9.04M License Revenue $0.00 Revenue $9.04M Operating expenses $103.25M Operating income -$94.20M Research & development $87.65M Pre-tax income -$89.81M Income tax -$271.00K Net income -$89.54M
Type Of Arrangement Separate filed amounts; connecting flows are not established. Components and totals may overlap.
NRIX revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Pfizer $5.00M Sanofi Agreement $2.00M Revenue $9.04M Operating expenses $103.25M Operating income -$94.20M Research & development $87.65M Pre-tax income -$89.81M Income tax -$271.00K Net income -$89.54M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-05-31 $9.04M $87.65M $103.25M -$271.00K -$89.53M 2026-02-28 $6.25M $84.14M $98.75M $0.00 -$87.17M 2025-11-30 $13.58M* $83.02M* $96.67M* $0.00* -$78.22M* 2025-08-31 $7.89M $86.12M $99.28M $0.00 -$86.42M 2025-05-31 $44.06M $78.10M $92.38M $760.00K -$43.46M 2025-02-28 $18.45M $69.66M $81.32M $0.00 -$56.35M 2024-08-31 $12.59M $55.48M $67.20M $82.00K -$48.96M 2024-05-31 $12.09M $48.92M $60.63M $90.00K -$44.55M 2024-02-29 $16.59M $50.01M $61.80M $90.00K -$41.52M 2023-08-31 $18.47M $47.86M $58.48M $0.00 -$36.98M 2023-05-31 $30.68M $45.76M $57.44M $0.00 -$24.28M 2023-02-28 $12.69M $45.82M $55.64M $0.00 -$40.73M 2022-08-31 $10.79M $47.76M $57.51M $0.00 -$45.71M 2022-05-31 $11.43M $47.49M $57.15M $0.00 -$45.40M 2022-02-28 $9.62M $43.14M $52.37M $0.00 -$42.53M 2021-08-31 $10.25M $30.91M $39.25M -$123.00K -$28.84M 2021-05-31 $7.09M $25.99M $33.51M $139.00K -$26.38M 2021-02-28 $5.01M $23.00M $29.53M $71.00K -$24.27M 2020-11-30 $6.69M (m) (m) (m) -$19.91M 2020-08-31 $4.08M $18.94M $23.28M $0.00 -$18.52M 2020-05-31 $4.18M $14.14M $17.41M -$20.59M $7.58M 2020-02-29 $2.86M $12.97M $15.42M $11.00K -$12.39M 2019-11-30 $1.86M (m) (m) (m) -$13.52M 2019-08-31 $10.58M $11.01M $13.19M $10.00K -$2.43M 2019-05-31 $9.44M (m) (m) (m) -$3.07M 2019-02-28 $9.23M (m) (m) (m) -$2.69M
Revenue and expense 6 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-05-31 $15.29M $171.79M $201.99M -$271.00K -$176.71M 2025-05-31 $62.51M $147.76M $173.69M $760.00K -$99.81M 2024-05-31 $28.68M $98.93M $122.44M $180.00K -$86.06M 2023-05-31 $43.36M $91.58M $113.08M $0.00 -$65.01M 2022-05-31 $21.05M $90.63M $109.51M $0.00 -$87.93M 2021-05-31 $12.10M $49.00M $63.04M $210.00K -$50.66M 2020-05-31 $7.05M $27.11M $32.83M -$20.58M -$4.81M
Revenue and expense 9 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-08-31 $70.40M $233.88M $272.97M $760.00K -$186.24M 2024-08-31 $41.27M $154.41M $189.63M $262.00K -$135.02M 2023-08-31 $61.83M $139.44M $171.56M $0.00 -$101.99M 2022-08-31 $31.84M $138.39M $167.02M $0.00 -$133.64M 2021-08-31 $22.35M $79.90M $102.29M $87.00K -$79.49M 2020-08-31 $11.13M $46.05M $56.11M -$20.58M -$23.33M 2019-08-31 (m) $32.20M $37.92M $29.00K -$8.18M
Revenue and expense 12 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-11-30 $83.98M $316.90M $369.65M $760.00K -$264.46M 2024-11-30 $54.55M $221.63M $267.58M $270.00K -$193.57M 2023-11-30 $76.99M $189.15M $232.05M $0.00 -$143.95M 2022-11-30 $38.63M $184.50M $222.49M $0.00 -$180.36M 2021-11-30 $29.75M $116.43M $147.64M $131.00K -$117.19M 2020-11-30 $17.82M $66.49M $82.80M -$20.54M -$43.24M 2019-11-30 $31.11M $45.02M $53.35M $239.00K -$21.70M